174 related articles for article (PubMed ID: 3922824)
21. Gonadotropin-releasing hormone agonist analog-induced steroidogenic lesion in the neonatal rat testis: evidence for direct gonadal action.
Huhtaniemi IT; Clayton RN; Catt KJ
Endocrinology; 1984 Jul; 115(1):233-8. PubMed ID: 6329649
[TBL] [Abstract][Full Text] [Related]
22. Intratesticular regulation of testosterone secretion: comparison of the effects and interactions of hCG, an LHRH agonist and testicular interstitial fluid on Leydig cell testosterone secretion in vitro.
Sharpe RM
Mol Cell Endocrinol; 1985 Jul; 41(2-3):247-55. PubMed ID: 3160620
[TBL] [Abstract][Full Text] [Related]
23. Effects of an LHRH agonist on endocrine function, LHRH receptor and LH/hCG receptor in the pituitary-gonadal axis of male rats.
Komatsu M; Iwahana H; Mitsuhashi S
Endocrinol Jpn; 1986 Apr; 33(2):185-95. PubMed ID: 3019649
[TBL] [Abstract][Full Text] [Related]
24. Antifertility effects of luteinizing hormone-releasing hormone (LHRH) agonists.
Labrie F; Bélanger A; Kelly PA; Séguin C; Cusan L; Lefebvre FA; Reeves JJ; Lemay A; Faure N; Gourdeau Y; Raynaud JP
Prog Clin Biol Res; 1981; 74():273-91. PubMed ID: 6275404
[TBL] [Abstract][Full Text] [Related]
25. Changes in plasma steroid levels after single administration of hCG or LHRH agonist analogue in dog and rat.
Tremblay Y; Belanger A
J Steroid Biochem; 1985 Mar; 22(3):315-20. PubMed ID: 2581068
[TBL] [Abstract][Full Text] [Related]
26. Lack of a direct effect of gonadotropin hormone-releasing hormone agonist on human testicular steroidogenesis.
Rajfer J; Sikka SC; Swerdloff RS
J Clin Endocrinol Metab; 1987 Jan; 64(1):62-7. PubMed ID: 3023429
[TBL] [Abstract][Full Text] [Related]
27. New hormonal therapy in prostate cancer: combined use of a pure antiandrogen and an LHRH agonist.
Labrie F; Dupont A; Belanger A; Lefebvre FA; Cusan L; Raynaud JP; Husson JM; Fazekas AT
Horm Res; 1983; 18(1-3):18-27. PubMed ID: 6411578
[TBL] [Abstract][Full Text] [Related]
28. Mice are insensitive to the antitesticular effects of luteinizing hormone-releasing hormone agonists.
Wang NG; Sundaram K; Pavlou S; Rivier J; Vale W; Bardin CW
Endocrinology; 1983 Jan; 112(1):331-5. PubMed ID: 6291919
[TBL] [Abstract][Full Text] [Related]
29. Effects of gonadotropin-releasing hormone receptor blockade on rat testicular gonadotropin and lactogen receptors, steroidogenesis, and responses to human chorionic gonadotropin stimulation.
Huhtaniemi IT; Catt KJ
Endocrinology; 1985 Jan; 116(1):281-7. PubMed ID: 2981066
[TBL] [Abstract][Full Text] [Related]
30. Steroidogenesis in HCG-responsive Leydig cell tumor variants.
Lacroix A; Ascoli M; Puett D; McKenna TJ
J Steroid Biochem; 1979 Jun; 10(6):669-75. PubMed ID: 314019
[No Abstract] [Full Text] [Related]
31. Multiple regulation of testicular steroidogenesis.
Rommerts FF; Teerds K; Themmen AP; van Noort M
J Steroid Biochem; 1987; 27(1-3):309-16. PubMed ID: 2826890
[TBL] [Abstract][Full Text] [Related]
32. Direct effect of the luteinizing hormone releasing hormone analog D-Trp6-Pro9-Net-LHRH on rat testicular steroidogenesis.
D'Agata R; Cassorla F; Munabi AK; Mericq V; Gelato MC; Albertson BD; Loriaux DL
Steroids; 1984 Feb; 43(2):201-7. PubMed ID: 6395451
[TBL] [Abstract][Full Text] [Related]
33. Stimulatory effect of LHRH and its agonists on Leydig cell steroidogenesis in vitro.
Sharpe RM; Cooper I
Mol Cell Endocrinol; 1982 Apr; 26(1-2):141-50. PubMed ID: 6177569
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of testicular androgen biosynthesis by chronic administration of a potent LHRH agonist in adult men.
Faure N; Lemay A
Arch Androl; 1985; 14(2-3):95-106. PubMed ID: 2933008
[TBL] [Abstract][Full Text] [Related]
35. Modulation by sex steroids and [D-Trp6, Des-Gly-NH2(10)]luteinizing hormone (LH)-releasing hormone ethylamide of alpha-subunit and LH beta messenger ribonucleic acid levels in the rat anterior pituitary gland.
Simard J; Labrie C; Hubert JF; Labrie F
Mol Endocrinol; 1988 Sep; 2(9):775-84. PubMed ID: 2459604
[TBL] [Abstract][Full Text] [Related]
36. Pituitary-testicular function is suppressed by an LHRH antagonist but not by an LHRH agonist in the marmoset monkey.
Lunn SF; Dixson AF; Sandow J; Fraser HM
J Endocrinol; 1990 May; 125(2):233-9. PubMed ID: 2165119
[TBL] [Abstract][Full Text] [Related]
37. Pituitary-testicular function of prostatic cancer patients during treatment with a gonadotropin-releasing hormone agonist analog. II. Endocrinology and histology of the testis.
Huhtaniemi I; Nikula H; Parvinen M; Rannikko S
J Androl; 1987; 8(6):363-73. PubMed ID: 3123446
[TBL] [Abstract][Full Text] [Related]
38. Testicular enzymes related to steroid metabolism.
Tamaoki Bi; Inano H; Suzuki K
Curr Top Mol Endocrinol; 1975; 2():123-32. PubMed ID: 1236065
[No Abstract] [Full Text] [Related]
39. The different mechanisms for suppression of pituitary and testicular function.
Sandow J; Engelbart K; von Rechenberg W
Med Biol; 1986; 63(5-6):192-200. PubMed ID: 3010006
[TBL] [Abstract][Full Text] [Related]
40. Proopiomelanocortin-derived peptides in testicular interstitial fluid: characterization and changes in secretion after human chorionic gonadotropin or luteinizing hormone-releasing hormone analog treatment.
Valenca MM; Negro-Vilar A
Endocrinology; 1986 Jan; 118(1):32-7. PubMed ID: 3000742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
